[ Price : $8.95]
FDA posts a corrected and updated list of New England Compounding Center customers who received product on or after 5/21.[ Price : $8.95]
House and Senate leaders float a pharmaceutical track and trace discussion draft that would require FDA to publish track and trace...[ Price : $8.95]
Amneal asks FDA to deny a Reckitt Benckiser petition seeking to require specific actions by companies pursuing ANDAs for generic S...[ Price : $8.95]
CDER issues MAPPs on clinical consultative procedures for drugs regulated by the Office of New Drugs and for cancer drugs.[ Price : $8.95]
FDA accepts an Ariad Pharmaceuticals NDA for accelerated and priority review for ponatinib for patients with chronic myeloid leuke...[ Price : $8.95]
Bayer HealthCare says the CHEST-1 Phase 3 trial met its primary endpoint in evaluating riociguat in patients with pulmonary hypert...[ Price : $8.95]
FDA sends United Therapeutics a complete response letter declining to approve its oral treprostinil for treating pulmonary arteria...[ Price : $8.95]
FDA approves SpineSmiths VisuALIF Challenging Access Plate System, an extension to its anterior lumbar interbody fusion device to ...